July 5, 2016
LA JOLLA—The Salk Institute will celebrate 21 years of Symphony at Salk, its signature concert under the stars, with Broadway luminary Kelli O’Hara and the incomparable San Diego Symphony led by guest conductor Maestro Thomas Wilkins on Saturday, August 20.
The gala evening concert on the courtyard of the Louis Kahn-designed Institute will showcase O’Hara performing her Broadway showstoppers and selections from the Great American Songbook. Her portrayal of Anna Leonowens in the critically acclaimed revival of The King and I garnered her the 2015 Tony Award for Best Leading Actress in a Musical. Since her Broadway debut in Jekyll & Hyde in 2000, she has moved from one critical and commercial success to another, earning numerous Tony, Drama Desk, Drama League and Outer Critics Circle nominations. A recent New York Times review of her operatic turn in Dido and Aeneas raved, “Ms. O’Hara can sign a Rodgers and Hammerstein number as if she were talking to you, while still bringing exquisite sound to her phrases.”
Individual tickets for Symphony at Salk are $300 and include a champagne reception and gourmet dinner. All proceeds support the Institute’s wide-ranging scientific inquiries that have yielded more than 50 years of life-changing discoveries, directly influencing areas as diverse as cancer, Alzheimer’s Parkinson’s, metabolic diseases, ALS, schizophrenia, autism, spinal cord injuries, crop yields and world hunger. Proceeds also support Salk’s award-winning educational outreach programs that have helped generations of students discover their passion for research and explore careers in science.
Tickets can be purchased online at www.salk.edu/symphony. For more information, call (858) 597-0657.
Office of Communications
Tel: (858) 453-4100
press@salk.edu
Unlocking the secrets of life itself is the driving force behind the Salk Institute. Our team of world-class, award-winning scientists pushes the boundaries of knowledge in areas such as neuroscience, cancer research, aging, immunobiology, plant biology, computational biology and more. Founded by Jonas Salk, developer of the first safe and effective polio vaccine, the Institute is an independent, nonprofit research organization and architectural landmark: small by choice, intimate by nature, and fearless in the face of any challenge.
Your partnership allows our scientists to accelerate the pace of high-risk, high-reward discoveries that have the potential to benefit the health of all humanity-be it cancer, Alzheimer’s disease, climate change, infectious diseases or more.
